Insider Trading Alert - PLAB, ACTG And CP Traded By Insiders

Yesterday, April 27, 2016, 50 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $147.00 to $15,185,780.00.

Highlighted Stocks Traded by Insiders:

Photronics (PLAB) - FREE Research Report

Tyson Mitchell G, who is Director at Photronics, sold 2,400 shares at $11.00 on April 27, 2016. Following this transaction, the Director owned 70,979 shares meaning that the stake was reduced by 3.27% with the 2,400-share transaction.

The shares most recently traded at $11.03, up $0.03, or 0.27% since the insider transaction. Historical insider transactions for Photronics go as follows:

  • 4-Week # shares bought: 10,332
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 10,332
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 10,332
  • 24-Week # shares sold: 55,683

The average volume for Photronics has been 715,300 shares per day over the past 30 days. Photronics has a market cap of $736.0 million and is part of the technology sector and electronics industry. Shares are down 10.6% year-to-date as of the close of trading on Wednesday.

Photronics, Inc., together with its subsidiaries, manufactures and sells photomasks in the United States, Taiwan, Korea, Europe, and internationally. The company has a P/E ratio of 12.9. Currently, there are 4 analysts who rate Photronics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PLAB - FREE

TheStreet Quant Ratings rates Photronics as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Photronics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Acacia Research (ACTG) - FREE Research Report

Walsh Frank E Iii, who is Director at Acacia Research, bought 35,000 shares at $4.13 on April 27, 2016. Following this transaction, the Director owned 35,000 shares meaning that the stake was boosted by 100% with the 35,000-share transaction.

Key Marvin E, who is Chief Executive Officer at Acacia Research, bought 55,000 shares at $4.15 on April 27, 2016. Following this transaction, the Chief Executive Officer owned 190,833 shares meaning that the stake was boosted by 40.49% with the 55,000-share transaction.

The shares most recently traded at $4.59, up $0.44, or 9.66% since the insider transaction. Historical insider transactions for Acacia Research go as follows:

  • 4-Week # shares bought: 139,196
  • 4-Week # shares sold: 34,273
  • 12-Week # shares bought: 139,196
  • 12-Week # shares sold: 34,273
  • 24-Week # shares bought: 193,997
  • 24-Week # shares sold: 34,273

The average volume for Acacia Research has been 795,100 shares per day over the past 30 days. Acacia Research has a market cap of $229.6 million and is part of the services sector and diversified services industry. Shares are up 3.5% year-to-date as of the close of trading on Wednesday.

Acacia Research Corporation, through its subsidiaries, invests in, develops, licenses, and enforces patented technologies in the United States. The stock currently has a dividend yield of 13.59%. Currently, there is 1 analyst who rates Acacia Research a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACTG - FREE

TheStreet Quant Ratings rates Acacia Research as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Acacia Research Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Canadian Pacific Railway (CP) - FREE Research Report

Paull Matthew H, who is Director at Canadian Pacific Railway, bought 1,000 shares at $143.89 on April 27, 2016. Following this transaction, the Director owned 1,000 shares meaning that the stake was boosted by 100% with the 1,000-share transaction.

Edwards Peter John, who is VP HR & Labour Relations at Canadian Pacific Railway, bought 1 shares at $147.00 on April 27, 2016. Following this transaction, the VP HR & Labour Relations owned 1,033 shares meaning that the stake was boosted by 0.1% with the 1-share transaction.

The shares most recently traded at $145.56, down $1.44, or 0.99% since the insider transaction.

The average volume for Canadian Pacific Railway has been 1.0 million shares per day over the past 30 days. Canadian Pacific Railway has a market cap of $21.9 billion and is part of the services sector and transportation industry. Shares are up 13.82% year-to-date as of the close of trading on Wednesday.

Canadian Pacific Railway Limited, together with its subsidiaries, operates a transcontinental railway in Canada and the United States. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 18.6. Currently, there are 13 analysts who rate Canadian Pacific Railway a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CP - FREE

TheStreet Quant Ratings rates Canadian Pacific Railway as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, notable return on equity, expanding profit margins and growth in earnings per share. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Canadian Pacific Railway Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing